{Reference Type}: Journal Article
{Title}: Influence of tumour grade on disease survival in male breast cancer patients: a systematic review.
{Author}: Kinsey-Trotman S;Nguyen A;Edwards S;Swalling A;Dasari P;Walsh D;Ingman WV;
{Journal}: Breast Cancer Res Treat
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 2
{Factor}: 4.624
{DOI}: 10.1007/s10549-024-07446-z
{Abstract}: <B>OBJECTIVE: </B>Histological grading of tumours is a well-established biomarker used to guide treatment in female breast cancer. However, its significance in male breast cancer remains unclear. This systematic review investigates the prognostic significance of tumour grade in relation to breast cancer-specific survival (BCSS) in male breast cancer patients undergoing surgery.<BR><B>METHODS: </B>MEDLINE, PUBMED Central and EMBASE databases were searched to identify randomised trials and observational studies related to male breast neoplasms, tumour grading, recurrence, and survival.<BR><B>RESULTS: </B>A total of fifteen observational type studies were included in the review. A significant association between tumour grade and BCSS was reported in a majority of studies. This association was most evident with regard to high-grade (grade III) compared to low grade (grade I) tumours, with a significant relationship in 4 out of 4 studies. For intermediate-grade II tumours an association was demonstrated in a minority of studies.<BR><B>CONCLUSIONS: </B>This study confirms an association between high-grade male breast cancers and poorer disease-specific survival, however, the significance of intermediate-grade tumours remains unclear. Further research is required to investigate the biology of male breast cancer in relation to histological grade and optimally define intermediate-grade disease.